Tryton brings stents to market in Europe
Published: Sat, Sep. 27, 2008 12:30AM
Modified Sat, Sep. 27, 2008 01:40AM
E-Mail
Print
tool name
closeTryton Medical, a small medical device company that moved its headquarters from Boston to Durham this year, announced Friday that it has started to bring its first product to market in Europe.
The company, which has a handful of employees, has developed a stent that prevents blockages in small blood vessels and has started to sell it in the Netherlands. Stents are scaffolds that are implanted to prop open blood vessels and prevent blockages that can lead to heart attacks.
The metal stents now on the market tend to be too large and difficult to implant in some small vessels. The smaller stents Tryton is targeting have yet to be tested in the United States.
More Business
Get it all with convenient home delivery of The News & Observer.
The News & Observer is pleased to be able to offer its users the opportunity to make comments and hold conversations online. However, the interactive nature of the internet makes it impracticable for our staff to monitor each and every posting.
Since The News & Observer does not control user submitted statements, we cannot promise that readers will not occasionally find offensive or inaccurate comments posted on our website. In addition, we remind anyone interested in making an online comment that responsibility for statements posted lies with the person submitting the comment, not The News and Observer.
If you find a comment offensive, clicking on the exclamation icon will flag the comment for review by the administrators, we are counting on the good judgment of all our readers to help us.
